
Payers are becoming more receptive to a different approach for paying for addiction treatment and recovery services, as evidenced by the formation of a new healthcare alliance that aims to redesign the structure and payment of these services.

Payers are becoming more receptive to a different approach for paying for addiction treatment and recovery services, as evidenced by the formation of a new healthcare alliance that aims to redesign the structure and payment of these services.

If all consumers had a high understanding of how to navigate the healthcare system, health insurers could save billions of dollars a year. Here’s what you should do.

Here’s how healthcare can do more to help patients learn more about their health to better prepare them to participate in their own treatment.

Glucose monitoring technology could become the go-to management strategy in a few years. Here’s where we are and where we are going.

Here are 4 key ways healthcare executives can leverage community resources to strengthen the availability of tools that support recovery from opioid addiction.

Payers struggle to determine the appropriate criteria for covering innovative treatments and providers want to increase patient access. Patients’ lives can hang in the balance.

A South Korean study may contribute to the improvement of personalized therapeutic outcomes for rheumatoid arthritis by expanding the scope of molecular imaging.

NORC at the University of Chicago set out to understand more Americans’ experiences with surprise billing. You won’t believe what they found.

A new study on the overlap between the causes of rheumatoid arthritis and Huntington’s disease opens up new therapeutic targets and drugs for both conditions.

Onboarding new oncology patients can be a delicate process to help them prepare for their care journey. Here are the first steps.

Surprising findings from the largest study to date investigating the genetics of osteoporosis and fracture risk.

While promising new options keep entering the scene, high costs can be problematic to patients and healthcare organizations. Here are some ways to cope.

The latest lymphoma research continues to bring new hope for patents, families and care providers. In looking at such advances, here are four things to know.

Successful hospitals share the strategies they have used to reduce readmissions.


These six medical conditions often accompany COPD, and providers should heed them as warning signs.

Progress in treating chronic obstructive pulmonary disease (COPD) is stymied by many factors. Here are the most problematic.


Value-based reimbursement models require different leadership to align the practice and move it forward around a team-based model of care.

A report by eHealth, Inc., has surprising findings about seniors transitioning from unsubsidized ACA plans into Medicare

Bradford Curtis, MD, FAAP, vice president and senior medical director at OptumRx, talks with Managed Healthcare Executive Editorial Advisor David Calabrese, RPh, MHP, about the future of provider engagement.

Promising new technology/biotechnology is on the horizon for migraine sufferers, according to a headache expert from Cleveland Clinic.

A new forecast reveals an important focus point for healthcare execs in the quest to manage pharma costs.


Cancer is one of the top deadliest diseases in the world and can be difficult to treat. We want to hear from you about your current challenges and what you think about future prospects in cancer therapy.